CatalystCorporate
Ultragenyx wins accelerated approval of gene therapy for glycogen storage disease
Accelerated FDA approval marks a major regulatory catalyst for Ultragenyx's gene therapy pipeline.
What changed
Accelerated FDA approval marks a major regulatory catalyst for Ultragenyx's gene therapy pipeline.
Why it matters
Accelerated FDA approval marks a major regulatory catalyst for Ultragenyx's gene therapy pipeline. — impact context not separately stored; see What changed.
← Dashboard
Aug 20, 2026 01:27 AM ET